The serum LOX level of A alleles was found to be significantly higher in ovarian cancer cases as compared to control, pointing towards the fact that active LOX, cleaved from the pro-enzyme in the extra-cellular environment, is able to re-enter the cells, thereby influencing the serum LOX levels. The gene discussed is LOX; the disease is ovarian cancer.